Antidepressant-Like Effect of Ropren® in β-Amyloid-(25–35) Rat Model of Alzheimer’s Disease with Altered Levels of Androgens
Crossref DOI link: https://doi.org/10.1007/s12035-016-9848-8
Published Online: 2016-03-19
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Soultanov, Vagif
Fedotova, Julia
Nikitina, Tamara
Roschin, Victor
Ordyan, Natalia
Hritcu, Lucian http://orcid.org/0000-0001-6981-4174
Funding for this research was provided by:
Solagran Limited supplied the Ropren.
Text and Data Mining valid from 2016-03-19